Revolution Medicines Announces Proposed $750M Common Stock Offering And $250M Convertible Senior Notes Offering

Benzinga Newsdesk www.benzinga.com Neutral 92.1%

Neg 0% Neu 92.1% Pos 0%

Comments

No comments yet. Be the first!